- Home
- GME vs EXEL Comparison
GME vs EXEL Comparison
Compare GME & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GME
- EXEL
- Stock Information
- Founded
- GME 1996
- EXEL 1994
- Country
- GME United States
- EXEL United States
- Employees
- GME N/A
- EXEL N/A
- Industry
- GME Electronics Distribution
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GME Consumer Discretionary
- EXEL Health Care
- Exchange
- GME Nasdaq
- EXEL Nasdaq
- Market Cap
- GME 10.5B
- EXEL 9.8B
- IPO Year
- GME 2002
- EXEL 2000
- Fundamental
- Price
- GME $26.77
- EXEL $36.50
- Analyst Decision
- GME Sell
- EXEL Buy
- Analyst Count
- GME 1
- EXEL 18
- Target Price
- GME $10.00
- EXEL $37.59
- AVG Volume (30 Days)
- GME 7.3M
- EXEL 2.3M
- Earning Date
- GME 06-06-2025
- EXEL 05-13-2025
- Dividend Yield
- GME N/A
- EXEL N/A
- EPS Growth
- GME 1550.00
- EXEL 170.77
- EPS
- GME 0.33
- EXEL 1.76
- Revenue
- GME $3,823,000,000.00
- EXEL $2,168,701,000.00
- Revenue This Year
- GME N/A
- EXEL $5.78
- Revenue Next Year
- GME N/A
- EXEL $10.94
- P/E Ratio
- GME $81.15
- EXEL $20.74
- Revenue Growth
- GME N/A
- EXEL 18.50
- 52 Week Low
- GME $15.35
- EXEL $20.14
- 52 Week High
- GME $64.83
- EXEL $40.26
- Technical
- Relative Strength Index (RSI)
- GME 53.42
- EXEL 45.67
- Support Level
- GME $25.67
- EXEL $35.34
- Resistance Level
- GME $28.35
- EXEL $40.26
- Average True Range (ATR)
- GME 0.88
- EXEL 1.21
- MACD
- GME -0.18
- EXEL -0.09
- Stochastic Oscillator
- GME 40.86
- EXEL 29.79
About GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.